NO20023976D0 - Endoparasittisidisk middel - Google Patents

Endoparasittisidisk middel

Info

Publication number
NO20023976D0
NO20023976D0 NO20023976A NO20023976A NO20023976D0 NO 20023976 D0 NO20023976 D0 NO 20023976D0 NO 20023976 A NO20023976 A NO 20023976A NO 20023976 A NO20023976 A NO 20023976A NO 20023976 D0 NO20023976 D0 NO 20023976D0
Authority
NO
Norway
Prior art keywords
endoparasitic
acid
endoparasitic acid
Prior art date
Application number
NO20023976A
Other languages
English (en)
Other versions
NO328949B1 (no
NO20023976L (no
Inventor
Jochen Kalbe
Michael Traeubel
Georg Von Samson-Himmelstjerna
Achim Harder
Michael Stegemann
Norbert Mencke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20023976D0 publication Critical patent/NO20023976D0/no
Publication of NO20023976L publication Critical patent/NO20023976L/no
Publication of NO328949B1 publication Critical patent/NO328949B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20023976A 2000-02-22 2002-08-21 Endoparasittiske sammensetninger, fremgangsmate for fremstilling derav samt anvendelse av cyklodepsipeptid NO328949B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Publications (3)

Publication Number Publication Date
NO20023976D0 true NO20023976D0 (no) 2002-08-21
NO20023976L NO20023976L (no) 2002-10-21
NO328949B1 NO328949B1 (no) 2010-06-28

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023976A NO328949B1 (no) 2000-02-22 2002-08-21 Endoparasittiske sammensetninger, fremgangsmate for fremstilling derav samt anvendelse av cyklodepsipeptid

Country Status (25)

Country Link
US (1) US20030125244A1 (no)
EP (1) EP1259250B1 (no)
JP (2) JP5596249B2 (no)
KR (1) KR100755414B1 (no)
CN (1) CN1309415C (no)
AR (2) AR028218A1 (no)
AT (1) ATE343394T1 (no)
AU (2) AU4060501A (no)
BR (1) BR0108562B1 (no)
CA (1) CA2400610C (no)
CZ (1) CZ300242B6 (no)
DE (2) DE10008128A1 (no)
DK (1) DK1259250T3 (no)
ES (1) ES2274871T3 (no)
HK (1) HK1054326B (no)
HU (1) HUP0204554A3 (no)
IL (2) IL150988A0 (no)
MX (1) MXPA02008210A (no)
NO (1) NO328949B1 (no)
NZ (1) NZ520856A (no)
PL (1) PL203999B1 (no)
PT (1) PT1259250E (no)
RU (1) RU2292905C2 (no)
WO (1) WO2001062268A1 (no)
ZA (1) ZA200205982B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
EP1561820B1 (en) * 2002-11-12 2008-12-31 The Kitasato Institute Anthelmintic substance fki-1033 and process for producing the same
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
MX2011002166A (es) 2008-08-28 2011-04-07 Pfizer Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN107835818B (zh) * 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
KR20220003663A (ko) 2015-12-28 2022-01-10 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 뎁시펩티드 화합물
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
TWI861178B (zh) 2019-08-14 2024-11-11 法商維多奎諾公司 用於控制寄生蟲之組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
CA2132199C (en) * 1992-03-17 2000-01-18 Hitoshi Nishiyama Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
AU739393B2 (en) * 1998-03-19 2001-10-11 Merck Sharp & Dohme Corp. Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
JP5596249B2 (ja) 2014-09-24
DE10008128A1 (de) 2001-08-23
US20030125244A1 (en) 2003-07-03
AU2001240605B2 (en) 2005-04-21
HUP0204554A3 (en) 2005-05-30
KR100755414B1 (ko) 2007-09-04
CA2400610C (en) 2013-01-22
ES2274871T3 (es) 2007-06-01
MXPA02008210A (es) 2003-01-28
NO328949B1 (no) 2010-06-28
HUP0204554A2 (en) 2003-05-28
CZ300242B6 (cs) 2009-03-25
PT1259250E (pt) 2007-01-31
EP1259250B1 (de) 2006-10-25
NZ520856A (en) 2005-04-29
JP2003523397A (ja) 2003-08-05
BR0108562A (pt) 2002-11-12
DE50111315D1 (de) 2006-12-07
DK1259250T3 (da) 2007-02-26
CZ20022867A3 (cs) 2003-01-15
AR085989A2 (es) 2013-11-13
CA2400610A1 (en) 2001-08-30
CN1404397A (zh) 2003-03-19
AR028218A1 (es) 2003-04-30
IL150988A0 (en) 2003-02-12
RU2002125493A (ru) 2004-03-20
KR20020072577A (ko) 2002-09-16
JP2012107024A (ja) 2012-06-07
PL357551A1 (en) 2004-07-26
HK1054326A1 (en) 2003-11-28
HK1054326B (zh) 2007-11-09
PL203999B1 (pl) 2009-11-30
ATE343394T1 (de) 2006-11-15
RU2292905C2 (ru) 2007-02-10
WO2001062268A1 (de) 2001-08-30
ZA200205982B (en) 2003-07-28
BR0108562B1 (pt) 2013-03-05
IL150988A (en) 2011-06-30
CN1309415C (zh) 2007-04-11
EP1259250A1 (de) 2002-11-27
NO20023976L (no) 2002-10-21
AU4060501A (en) 2001-09-03

Similar Documents

Publication Publication Date Title
PT1259508E (pt) Novos biarilcarboxamidas
ATE290000T1 (de) Muscarinagonisten
ATA2932001A (de) Schneefräse
FI20002644A0 (fi) Liitäntäalusta
DE60128494D1 (de) Wachstumhormonsekretionsförderer
DE50102988D1 (de) Bodenwischer
DE50104056D1 (de) Gewichtsmanschette
DE50115290D1 (de) Wasserklosett
ATE262530T1 (de) Indolochinazolinone
DE50104651D1 (de) Fahrzeugfaltverdeck
DE60025150D1 (de) Brennkammerverwirbelungsanordnung
DE60009651D1 (de) Hochfrequenzscalter
ATE509008T1 (de) Sulfonylguanidine
DE60014025D1 (de) Turbomaschinen
DE50100817D1 (de) Kugelgelenk
AR027931A1 (es) Antitranspirantes
DE50007634D1 (de) Kardioplegieballonkatheter
DE10052925B4 (de) Schaukelbett
ATE476423T1 (de) Benzoylpyridazine
DE10195909T1 (de) Viehfüttervorrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
ATE284887T1 (de) Thienopyrrolidinone
DE50010192D1 (de) Intaglio-druckmaschine
DE10054120B4 (de) Aufsparrendämmelement

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired